
The world’s largest publisher Penguin Random House and rival Simon & Schuster have called off a $2.2 billion deal to merge, the New York Times reported.
Penguin, a subsidiary of German media giant Bertelsmann, is obligated to pay Paramount, Simon & Schuster’s parent company, a $200 million termination fee, according to an SEC filing from Paramount. The proposed $2.17 billion deal was announced in November 2020. Bertelsmann had initially said it would appeal a US judge’s decision which said its bid to acquire Simon & Schuster was illegal because it would hit authors’ pay.
On Monday Bertelsmann said that it “will advance the growth of its global book publishing business without the previously planned merger of Penguin Random House and Simon & Schuster.”
Related: US Judge Blocks Penguin Random House From Buying Rival Simon & Schuster
Reuters reported on Sunday that the German company was unable to convince Paramount Global, Simon & Schuster’s owner, to extend their deal agreement and appeal the judge’s decision.
In late October, US District Court Judge Florence Pan ruled the combination of the book publishing giants would illegally reduce competition. The Justice Department had sued about a year ago to stop the merger, one of the first major antitrust actions from the Biden administration.
“Simon & Schuster is a highly valuable business with a recent record of strong performance,” Paramount said in a statement. “However, it is not video-based and therefore does not fit strategically within Paramount’s broader portfolio.”
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas